Nightingale Health and Estonian Biobank Agree Strategic Collaboration Aiming to Work Towards Estonian Biobank’s Nationwide Early Disease Prevention in Estonia
Finnish health tech company Nightingale Health Oy (“Nightingale”) and Estonian Biobank, population-based biobank of the Institute of Genomics at the University of Tartu (“EBB”) today announced long-term strategic collaboration. The aim of Estonian Biobank is to pioneer a global initiative to empower the entire population of Estonia with modern tools of personalized medicine to realize early disease prevention. The strategic collaboration between Nightingale and Estonian Biobank contributes to this aim. In the first phase of the collaboration Nightingale’s proprietary blood-testing